New Brunswick, New Jersey 08901


The purpose of this study is to investigate how behavioral treatments for alcohol use disorders affect behavior change.


Inclusion Criteria: Study inclusion criteria are such that study participants must: 1. meet a Diagnostic and Statistical Manual-IV (DSM-IV) alcohol abuse or dependence diagnosis based on the Diagnostic Interview Schedule - IV (DIS-IV); 2. consume a weekly average of at least 24 standard drinks during the baseline period to include at least 5 episodes of heavy drinking; 3. agree not to seek additional alcohol or other substance abuse treatment during the study period; 4. be at least 18 years of age; and 5. be sufficiently proficient in their English speaking ability to interact effectively with the research interviewer. Exclusion Criteria: - Individuals assessed as having a drug diagnosis that is more severe than their alcohol diagnosis (e.g., cocaine dependence and alcohol abuse, IV drug use), - a serious psychiatric diagnosis (e.g., uncontrolled schizophrenia or major depression) as well as those meeting criteria for organic brain impairment, as measured by the mini-mental status examination section of the DIS-IV will be precluded from study participation. In addition, - individuals reporting current enrollment in a substance abuse treatment program, - mandated to substance abuse treatment by a court order, or - severely socially unstable (e.g., homeless) also will be precluded from study participation.



Primary Contact:

Principal Investigator
Patrick R Clifford, PhD
Rutgers University School of Public Health

Christine M Davis, PhD
Phone: 732-235-5118

Backup Contact:


Location Contact:

New Brunswick, New Jersey 08901
United States

Patrick R Clifford, PhD
Phone: 732-235-5118

Site Status: Recruiting

Data Source:

Date Processed: January 21, 2020

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.